Zurich · London · Frankfurt
Independent transaction management for private capital.
Breslin supports institutional investors, corporates and founders on private equity secondaries, corporate finance and strategic transactions. Independent and Swiss, led by its partners since 1996.
Judgement you can defend
Partners who understand the asset before they structure the deal.
Breslin advises across life sciences, chemicals, energy, industrials and technology. The partners combine decades of banking and board experience with genuine technical depth, including doctorates in chemistry, biochemistry and immunology.
That range shapes how we advise. A chemicals portfolio, an energy platform, an industrial technology business or a biotech asset cannot be marketed as a commodity. Its value sits in what the company actually does, and the transaction has to be built around it. Breslin acts as adviser and, where appropriate, as principal. We are a long term strategic partner to our clients, not an intermediary placing assets.
What we do
Four practices, one standard.
- Secondaries
Private equity secondaries and externalisation
Portfolio sales, LP-led and GP-led processes, and the externalisation of non core assets.
- Corporate finance
Corporate finance and fundraising
Private placements, growth financing and structured capital, prepared to stand up to investor scrutiny.
- Partnering
Partnering, licensing and spin offs
Finding the counterparty that validates the technology and opens the path to scale.
- Primary & Strategic Transactions
Strategic transactions
Sell side and buy side mandates, divestments and carve outs in innovation led sectors.
Sector focus
Where our fluency runs deepest.
Life sciences
Biotech, pharma, medtech, diagnostics and digital health, from platform to portfolio.
Industrials & Chemicals
Industrial biotech, agro and food, and chemistry led businesses with technical depth.
Energy transition
Cleantech and new energy positions held by corporates, banks and funds.
Applied technology
Selected industrial technology and knowledge intensive businesses.
Insights
Recent analysis.
- Corporate Venture · Updated
What Corporate Venture Capital Accomplishes: Strategic Value, Models and the Full Lifecycle
Intelligence, a de-risked path to acquisition, financial optionality and disciplined realisation: what corporate venturing delivers.
→
- Venture Secondaries · AI and Compute
AI and Compute Secondaries in 2026: How Positions Change Hands, and How Quickly
Five routes into a position, the fee notation decoded, and how quickly a trade can close.
→
- Market Analysis · Venture
The Clarity Liquidity Index: What the Fifty Most-Traded Private Companies Say About the Pre-IPO Market
Hiive is now Clarity. How its index of the fifty most liquid pre-IPO names is built, and what it cannot tell you.
→
Partners and clients
Institutions Breslin has advised or worked alongside.
The Swiss base
Why it matters that Breslin is Swiss.
Breslin has been domiciled in Zurich since 1996. Clients gain from what that implies in practice: discretion and confidentiality as a professional norm, a stable political and financial environment, neutrality in cross border situations, and a regulatory culture built on rigour. Precision is a national habit. We treat it as a professional obligation.
Considering a transaction, a financing or a strategic review?
A first conversation is confidential and carries no obligation. It is answered by a partner.